Switch to: References

Add citations

You must login to add citations.
  1. Christianity and Psychedelic Medicine: A Pastoral Approach.Bryan McCarthy - 2023 - Christian Bioethics 29 (1):31-57.
    In recent years, researchers in the “psychedelic renaissance” have been reinvestigating the therapeutic potential of psychedelic compounds for conditions like post-traumatic stress disorder, clinical anxiety/depression, and addiction. Each of these has treatment-resistant cases, sometimes decades in the making, but studies employing psychedelics to address them are yielding impressive results. Given the evolving legal situation around these substances as well as corporate investment in them, their availability and appeal promise to increase. The question facing Christians is: How do these developments impact (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • (1 other version)Bioethics and conflicts of interest.Richard E. Ashcroft - 2004 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 35 (1):155-165.
    Bioethics has been subject to considerable social criticism in recent years. One criticism that has caused particular discomfort in the bioethics community is that bioethicists, because of the way their work is funded, are involved in profound conflicts of interest that undermine their title to be considered independent moral commentators on developments in biomedicine and biotechnology. This criticism draws its force from the assumption that bioethics is, or ought to be, a type of normative social criticism. Versions of this criticism (...)
    Download  
     
    Export citation  
     
    Bookmark   12 citations  
  • (1 other version)The commercial exploitation of ethics.Tim Lewens - 2004 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 35 (1):145-153.
    In the first part of this paper I consider whether an academic bioethicist is likely to change the arguments she is prepared to voice if she is in receipt of payment from a corporation. I argue that she is not, so long as a number of conditions are met regarding the size of payment, the values of the academic bioethics community, the degree to which she participates in that community, and the transparency of corporate involvements. In the second half I (...)
    Download  
     
    Export citation  
     
    Bookmark